Hundreds of therapies approved by the FDA and global regulatory agencies were supported by our scientists. We deliver the quality, speed, and scientific rigor that 2,500+ clients worldwide trust to advance their most promising drug candidates — because a partner you can trust helps reduce risk at every milestone.
- Discovery Services
- Preclinical Services
- Clinical Support Services
Company Facts
What We Stand For
Consultative
An extension of your team.
Direct access to study directors. No portals, no handoffs. Scientists who interpret results, recommend next steps, and adapt protocols as the science evolves.
Responsive
Matching your speed and rigor.
24-hour response to inquiries. On-time and right-first-time delivery tracked across every project, so milestones don’t slip.
Proven
25 years of expertise.
2,500+ clients. 5,000+ projects per year. Hundreds of therapies supported to IND. ISO 9001:2015 and GxP-compliant operations across four global sites.
Reasons to Believe
Trust & Credibility
- Hundreds of therapies supported to IND submission
- Industry’s largest kinase library
- 2,500+ clients worldwide
- ISO 9001:2015 certified quality management
- 25+ years of CRO expertise
- 6,000+ citations across 50+ scientific journals
Speed & Responsiveness
- Deadline-aligned reports
- Scope flexibility when priorities shift
- Fast quotes for standard studies
- 24-hour response to inquiries
- Direct study director access
- QTR and RFT tracked on every project
Preclinical Drug Discovery Platform
Reaction Biology’s team of PhD scientists will take your drug discovery project from target validation through hit identification and hit to lead phases and provide lead optimization studies either on a fee-for-service basis or as integrated partner.